The Proclaimsm (Proleukin® Observational Study to Evaluate Treatment Patterns and Clinical Response in Malignancy) Study: The Response Rates for High Dose Interleukin-2 (HD IL-2) Therapy

被引：0
|
作者：
Kaufman, Howard [1 ]
McDermott, David [2 ]
Morse, Michael [3 ]
Lowder, James [4 ]
Wong, Michael [5 ]
机构：
[1] Rush Univ, Chicago, IL 60612 USA
[2] Harvard Univ, Boston, MA 02115 USA
[3] Duke Univ, Durham, NC USA
[4] Prometheus Labs Inc, San Diego, CA USA
[5] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2012年 / 35卷 / 09期
关键词：
Interleukin-2; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：749 / 750
页数：2
相关论文
共 50 条
  • [1] Response to high-dose interleukin-2 (HD IL-2) therapy in patients with brain metastases from metastatic melanoma
    Powell, S. F.
    Dudek, A. Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] The Transient Nature of Significant Toxicities Associated With High Dose Interleukin (HD IL-2): Preliminary Data From The ProclaimSM Study
    Wong, Michael K.
    Kaufman, Howard L.
    Morse, Michael
    McDermott, David F.
    Lowder, James N.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 753 - 754
  • [3] Nausea and vomiting during high-dose interleukin-2 (HD IL-2) therapy.
    Fesler, Mark
    Chu, Melinda Bernabe
    Armbrecht, Eric
    Fosko, Scott
    Hsueh, Eddy C.
    Richart, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Maintenance interleukin-2 (IL-2) and sargramostim (GM-CSF) following high-dose IL-2 (HD IL-2) therapy for metastatic melanoma
    Chu, Melinda Bernabe
    Fesler, Mark
    Armbrecht, Eric
    Fosko, Scott
    Hsueh, Eddy C.
    Richart, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] High-dose interleukin-2 (HD IL-2) in the treatment of advanced melanoma: The University of Pittsburgh experience
    Davar, Diwakar
    Saul, Melissa
    Tarhini, Ahmad A.
    An Tran
    Trent, Kerry
    Sander, Cindy
    Kirkwood, John M.
    Tawbi, Hussein Abdul-Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Single-institution Outcome of High-dose Interleukin-2 (HD IL-2) Therapy for Metastatic Melanoma and Analysis of Favorable Response in Brain Metastases
    Powell, Steven
    Dudek, Arkadiusz Z.
    ANTICANCER RESEARCH, 2009, 29 (10) : 4189 - 4193
  • [7] Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry
    Fishman, M.
    Dutcher, J. P.
    Clark, J., I
    Alva, A.
    Miletello, G. P.
    Curti, B.
    Agarwal, Neeraj
    Hauke, R.
    Mahoney, K. M.
    Moon, H.
    Treisman, J.
    Tykodi, S. S.
    Daniels, G.
    Morse, M. A.
    Wong, M. K. K.
    Kaufman, H.
    Gregory, N.
    McDermott, D. F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [8] A phase II study of combined therapy with vemurafenib (vem) and high-dose interleukin-2 (aldesleukin; HD IL-2) in patients with metastatic melanoma
    Wargo, Jennifer Ann
    Lawrence, Donald P.
    Cooper, Zachary A.
    Frederick, Dennie T.
    Giobbie-Hurder, Anita
    Piris, Adriano
    Rubin, Krista M.
    Fadden, Riley
    Reuben, Alexandre
    Starker, Lee
    Flaherty, Keith
    Sharpe, Arlene
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
    Buchbinder, Elizabeth I.
    Gunturi, Anasuya
    Perritt, Jessica
    Dutcher, Janice
    Aung, Sandra
    Kaufman, Howard L.
    Ernstoff, Marc S.
    Miletello, Girald P.
    Curti, Brendan D.
    Daniels, Gregory A.
    Patel, Sapna P.
    Kirkwood, John M.
    Hallmeyer, Sigrun
    Clark, Joseph I.
    Gonzalez, Rene
    Richart, John M.
    Lutzky, Joe
    Morse, Michael A.
    Sullivan, Ryan J.
    McDermott, David F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [10] Impact of targeted therapy (TT) on survival of metastatic renal cell carcinoma (mRCC) patients treated with high dose interleukin-2 (HD IL-2): Analysis of the PROCLAIM HD IL-2 National Registry
    Clark, Joseph
    Morse, Michael
    Wong, Michael K. K.
    McDermott, David F.
    Kaufman, Howard
    Daniels, Gregory A.
    Hua, Hong
    Aung, Sandra
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345